Serum fetuin-A levels related with microalbuminuria in diet-induced obese rats

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Li, Yanyan ^a   Sun, Xiaodong ^a   Yu, Yerong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALBUMIN; FENOFIBRATE; FETUIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; CREATININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FATTY LIVER; INTRAABDOMINAL FAT; LIVER; MALE; MICROALBUMINURIA; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; WISTAR RAT; ALBUMINURIA; ANIMAL; BIOSYNTHESIS; BLOOD; GENETICS; HUMAN; LIPID DIET; METABOLISM; PATHOLOGY; SERUM; URINE;

ADIPONECTIN; ALBUMINURIA; ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; CREATININE; DIET, HIGH-FAT; HUMANS; LIVER; MALE; NF-KAPPA B; OBESITY; RATS; SERUM;

EID: 84874599749     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/795103     Document Type: Article

References (34)

1. Chang Y., Ryu S., Sung E., Woo H. Y., Oh E., Cha K., Jung E., Kim W. S., Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism: Clinical and Experimental 2008 57 4 569 576 2-s2.0-40049095342 10.1016/j.metabol.2007.11.022 (Pubitemid 351320606)
2. Targher G., Chonchol M., Zoppini G., Abaterusso C., Bonora E., Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? Journal of Hepatology 2011 54 5 1020 1029 2-s2.0-79954662342 10.1016/j.jhep.2010.11.007
3. Hwang S. T., Cho Y. K., Yun J. W., Park J. H., Kim H. J., Park D. I., Sohn C. I., Jeon W. K., Kim B. I., Rhee E. J., Oh K. W., Lee W. Y., Jin W., Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Internal Medicine Journal 2010 40 6 437 442 2-s2.0-77953838107 10.1111/j.1445-5994.2009.01979.x
4. Reinehr T., Roth C. L., Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. Journal of Clinical Endocrinology and Metabolism 2008 93 11 4479 4485 2-s2.0-57349109502 10.1210/jc.2008-1505 (Pubitemid 352789550)
5. Haukeland J. W., Dahl T. B., Yndestad A., Gladhaug I. P., Løberg E. M., Haaland T., Konopski Z., Wium C., Aasheim E. T., Johansen O. E., Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. European Journal of Endocrinology 2012 166 3 503 510
6. Ix J. H., Shlipak M. G., Brandenburg V. M., Ali S., Ketteler M., Whooley M. A., Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006 113 14 1760 1767 2-s2.0-33646690516 10.1161/CIRCULATIONAHA.105.588723 (Pubitemid 43958469)
7. Stefan N., Haring H. U., The metabolically benign and malignant fatty liver. Diabetes 2011 60 8 2011 2017
8. Buechler C., Wanninger J., Neumeier M., Adiponectin, a key adipokine in obesity related liver diseases. World Journal of Gastroenterology 2011 17 23 2801 2811 2-s2.0-79959672175 10.3748/wjg.v17.i23.2801
9. Kissebah A. H., Sonnenberg G. E., Myklebust J., Goldstein M., Broman K., James R. G., Marks J. A., Krakower G. R., Jacob H. J., Weber J., Martin L., Blangero J., Comuzzie A. G., Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14478 14483 2-s2.0-14344273991 10.1073/pnas.97.26.14478 (Pubitemid 32016601)
10. Vionnet N., Hani E. H., Dupont S., Gallina S., Francke S., Dotte S., de Matos F., Durand E., Lepretre F., Lecoeur C., Gallina P., Zekiri L., Dina C., Froguel P., Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosiome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. American Journal of Human Genetics 2000 67 6 1470 1480 2-s2.0-0033652271 10.1086/316887
11. Hennige A. M., Staiger H., Wicke C., Machicao F., Fritsche A., Häring H. U., Stefan N., Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008 3 3, article e1765 2-s2.0-46149124353 10.1371/journal.pone.0001765
12. Sharma K., RamachandraRao S., Qiu G., Usui H. K., Zhu Y., Dunn S. R., Ouedraogo R., Hough K., McCue P., Chan L., Falkner B., Goldstein B. J., Adiponectin regulates albuminuria and podocyte function in mice. Journal of Clinical Investigation 2008 118 5 1645 1656 2-s2.0-43049095682 10.1172/JCI32691 (Pubitemid 351632369)
13. 2- Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006 29 4 853 857 2-s2.0-33746367157 (Pubitemid 44115306)
14. DeAngelis R. A., Kovalovich K., Cressman D. E., Taub R., Normal liver regeneration in p50/nuclear factor B1 knockout mice. Hepatology 2001 33 4 915 924 2-s2.0-0035081675 10.1053/jhep.2001.23192 (Pubitemid 32246641)
15. Bonnet F., Marre M., Halimi J. M., Stengel B., Lange C., Laville M., Tichet J., Balkau B., Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study. Journal of Hypertension 2006 24 6 1157 1163 2-s2.0-33646834274 10.1097/01.hjh.0000226206.03560.ac (Pubitemid 43772324)
16. Palaniappan L., Carnethon M., Fortmann S. P., Association between microalbuminuria and the metabolic syndrome: NHANES III. American Journal of Hypertension 2003 16 11, part 1 952 958 2-s2.0-0142231533 10.1016/S0895-7061(03) 01009-4 (Pubitemid 37315495)
17. Chen J., Muntner P., Hamm L. L., Jones D. W., Batuman V., Fonseca V., Whelton P. K., He J., The metabolic syndrome and chronic kidney disease in U.S. adults. Annals of Internal Medicine 2004 140 3 167 I39 2-s2.0-0742266631
18. Kantartzis K., MacHann J., Schick F., Fritsche A., Häring H. U., Stefan N., The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 2010 53 5 882 889 2-s2.0-77952095022 10.1007/s00125-010-1663-6
19. Ketteler M., Bongartz P., Westenfeld R., Wildberger J. E., Mahnken A. H., Böhm R., Metzger T., Wanner C., Jahnen-Dechent W., Floege J., Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003 361 9360 827 833 2-s2.0-0037426081 10.1016/S0140-6736(03)12710-9 (Pubitemid 36331846)
20. Li M., Xu M., Bi Y., Song A., Liu Y., Li X., Ning G., Association between higher serum fetuin-A concentrations and abnormal albuminuria in middle-aged and elderly Chinese with normal glucose tolerance. Diabetes Care 2010 33 11 2462 2464 2-s2.0-79951704658 10.2337/dc10-0595
21. 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Annals of Clinical Biochemistry 2010 47 6 549 553 2-s2.0-78449301931 10.1258/acb.2010.010169
22. Brix J. M., Stingl H., Höllerl F., Schernthaner G. H., Kopp H. P., Schernthaner G., Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. Journal of Clinical Endocrinology and Metabolism 2010 95 11 4877 4881 2-s2.0-78049514118 10.1210/jc.2010-0148
23. Sharma K., The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney International 2009 76 2 145 148 2-s2.0-67649874800 10.1038/ki.2009.137
24. Savino A., Pelliccia P., Chiarelli F., Mohn A., Obesity-related renal injury in childhood. Hormone Research in Paediatrics 2010 73 5 303 311 2-s2.0-77954076182 10.1159/000308161
25. Pavan M., Ranganath R., PChudhari A., Shetty M., Obesity as an independent risk factor for the development of microalbuminuria. Nephro-Urology Monthly 2011 3 4 276 279
26. Marchesini G., Moscatiello S., di Domizio S., Forlani G., Obesity-associated liver disease. Journal of Clinical Endocrinology and Metabolism 2008 93 11, supplement 1 s74 s80 2-s2.0-55849127739 10.1210/jc.2008-1399
27. Wang Y., Mingyan Z., Lam K. S. L., Xu A., Protective roles of adiponectin in obesityrelated fatty liver diseases: mechanisms and therapeutic implications. Arquivos Brasileiros de Endocrinologia e Metabologia 2009 53 2 201 212 2-s2.0-67649411827
28. Videla L. A., Tapia G., Rodrigo R., Pettinelli P., Haim D., Santibãez C., Araya A. V., Smok G., Csendes A., Gutierrez L., Rojas J., Castillo J., Korn O., Maluenda F., Díaz J. C., Rencoret G., Poniachik J., Liver NF- B and AP-1 DNA binding in obese patients. Obesity 2009 17 5 973 979 2-s2.0-67349085771 10.1038/oby.2008.601
29. Li L., Chen L., Hu L., Liu Y., Sun H.-Y., Tang J., Hou Y.-J., Chang Y.-X., Tu Q., Feng G.-S., Shen F., Wu M.-C., Wang H.-Y., Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 2011 54 5 1620 1630
30. Dasgupta S., Bhattacharya S., Biswas A., Majumdar S. S., Mukhopadhyay S., Ray S., Bhattacharya S., NF- B mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochemical Journal 2010 429 3 451 462 2-s2.0-77955069684 10.1042/BJ20100330
31. Pal D., Dasgupta S., Kundu R., Maitra S., Das G., Mukhopadhyay S., Ray S., Majumdar S. S., Bhattacharya S., Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine 2012 18 8 1279 1285
32. Sarafidis P. A., Ruilope L. M., Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. American Journal of Nephrology 2006 26 3 232 244 2-s2.0-33746330410 10.1159/000093632 (Pubitemid 44114394)
33. Targher G., Marra F., Marchesini G., Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008 51 11 1947 1953 2-s2.0-53549112749 10.1007/s00125-008-1135-4
34. Rosenson R. S., Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients. Obesity 2009 17 3 504 509 2-s2.0-60849116123 10.1038/oby.2008.530